Delirium, insulin-like growth factor I, growth hormone in older inpatients.
Cognition
Delirium
Growth hormone
Insulin-like growth factor-I
Old age psychiatry
Older people
Pathophysiology
Physical illness
Journal
World journal of psychiatry
ISSN: 2220-3206
Titre abrégé: World J Psychiatry
Pays: United States
ID NLM: 101610480
Informations de publication
Date de publication:
19 Sep 2020
19 Sep 2020
Historique:
received:
30
12
2019
revised:
16
06
2020
accepted:
24
08
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Delirium is a common disorder in elderly medical inpatients with serious adverse outcomes and is characterized by sudden onset, disturbance in attention, awareness, consciousness and cognition, and often with behavioural disturbances. Central to understanding delirium, is understanding mechanisms by which body and brain wellbeing are linked and in particular how brain responses to bodily homeostatic stress is mediated. A number of studies have investigated the relationship between insulin-like growth factor I (IGF-I) and delirium in medically ill hospitalised patients with conflicting results. However, none have investigated growth hormone (GH) which is related to IGF-I To investigate the relationship between serum levels of IGF-I and GH, and the occurrence of delirium. Prospective, longitudinal, observational study. Consecutive elderly inpatients (aged 70+), were assessed twice weekly with Montreal cognitive assessment (MoCA), Confusion assessment method (CAM), Acute Physiology and Chronic Health Evaluation II. Delirium was defined using CAM. Previous history of dementia was evaluated with the Informant Questionnaire on Cognitive Decline in the Elderly. IGF-I and GH levels were estimated with the ELISA method. Generalized estimating equations (GEE) model was applied for the first five assessments to analyze those longitudinal data. The sample consisted of 198 participants (mean age 80.63 ± 6.81; range 70-97). Of these 92 (46.5%) were females. Eighty six (43.4%) were identified with a history of dementia. Incident or prevalent delirium during hospitalisation was identified with CAM in 40 participants (20.2%). Evaluation of missing values with Little's MCAR test indicated that they were missing completely at random (MCAR The results show that low levels of IGF-I, high levels of GH and low scores in cognition are independently associated with the occurrence of any delirium during the hospitalisation of medically ill older people. The results of the study supports the hypothesis that deficits in the immunoreactivity of the brain (low cerebral reserve) may be associated with delirium.
Sections du résumé
BACKGROUND
BACKGROUND
Delirium is a common disorder in elderly medical inpatients with serious adverse outcomes and is characterized by sudden onset, disturbance in attention, awareness, consciousness and cognition, and often with behavioural disturbances. Central to understanding delirium, is understanding mechanisms by which body and brain wellbeing are linked and in particular how brain responses to bodily homeostatic stress is mediated. A number of studies have investigated the relationship between insulin-like growth factor I (IGF-I) and delirium in medically ill hospitalised patients with conflicting results. However, none have investigated growth hormone (GH) which is related to IGF-I
AIM
OBJECTIVE
To investigate the relationship between serum levels of IGF-I and GH, and the occurrence of delirium.
METHODS
METHODS
Prospective, longitudinal, observational study. Consecutive elderly inpatients (aged 70+), were assessed twice weekly with Montreal cognitive assessment (MoCA), Confusion assessment method (CAM), Acute Physiology and Chronic Health Evaluation II. Delirium was defined using CAM. Previous history of dementia was evaluated with the Informant Questionnaire on Cognitive Decline in the Elderly. IGF-I and GH levels were estimated with the ELISA method. Generalized estimating equations (GEE) model was applied for the first five assessments to analyze those longitudinal data.
RESULTS
RESULTS
The sample consisted of 198 participants (mean age 80.63 ± 6.81; range 70-97). Of these 92 (46.5%) were females. Eighty six (43.4%) were identified with a history of dementia. Incident or prevalent delirium during hospitalisation was identified with CAM in 40 participants (20.2%). Evaluation of missing values with Little's MCAR test indicated that they were missing completely at random (MCAR
CONCLUSION
CONCLUSIONS
The results show that low levels of IGF-I, high levels of GH and low scores in cognition are independently associated with the occurrence of any delirium during the hospitalisation of medically ill older people. The results of the study supports the hypothesis that deficits in the immunoreactivity of the brain (low cerebral reserve) may be associated with delirium.
Identifiants
pubmed: 33014722
doi: 10.5498/wjp.v10.i9.212
pmc: PMC7515747
doi:
Types de publication
Journal Article
Langues
eng
Pagination
212-222Informations de copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare no potential financial interests.
Références
Clin Obstet Gynecol. 2001 Dec;44(4):893-901
pubmed: 11600869
Int Rev Psychiatry. 2009 Feb;21(1):30-42
pubmed: 19219711
Int J Geriatr Psychiatry. 2019 Oct;34(10):1438-1446
pubmed: 31058343
Curr Pharm Des. 2016;22(38):5879-5883
pubmed: 27526790
Clin Endocrinol (Oxf). 1991 Jul;35(1):47-54
pubmed: 1909610
Growth Horm IGF Res. 2000 Feb;10(1):1-13
pubmed: 10753587
Brain. 2012 Sep;135(Pt 9):2809-16
pubmed: 22879644
Dement Geriatr Cogn Disord. 2015;39(1-2):116-24
pubmed: 25413160
Age Ageing. 2009 May;38(3):326-32; discussion 251
pubmed: 19269948
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
Arch Gerontol Geriatr. 2014 Nov-Dec;59(3):593-8
pubmed: 25189345
Arch Gerontol Geriatr. 2018 Jul - Aug;77:13-18
pubmed: 29605680
Growth Horm IGF Res. 2003 Dec;13(6):361-70
pubmed: 14624771
Int Rev Psychiatry. 2009 Feb;21(1):74-85
pubmed: 19219714
JAMA. 2010 Jul 28;304(4):443-51
pubmed: 20664045
Psychol Med. 1994 Feb;24(1):145-53
pubmed: 8208879
Int J Geriatr Psychiatry. 2008 Sep;23(9):943-8
pubmed: 18481319
J Med Ethics. 2005 Mar;31(3):137-43
pubmed: 15738432
Dement Geriatr Cogn Disord. 2004;18(3-4):240-4
pubmed: 15286453
Gen Comp Endocrinol. 2018 Mar 1;258:119-133
pubmed: 28760716
Int Psychogeriatr. 2011 Sep;23(7):1175-81
pubmed: 21294938
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Mol Cell Endocrinol. 1998 May 25;140(1-2):95-9
pubmed: 9722175
Psychiatry Investig. 2016 May;13(3):327-32
pubmed: 27247600
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Geriatr Psychiatry Neurol. 2013 Sep;26(3):185-94
pubmed: 23864592
Int Psychogeriatr. 2015 Jun;27(6):883-9
pubmed: 25601222
J Psychosom Res. 2012 Mar;72(3):236-41
pubmed: 22325705
Neurobiol Dis. 2019 Dec;132:104541
pubmed: 31349033
Sheng Li Xue Bao. 2017 Oct 25;69(5):541-556
pubmed: 29063103
Noro Psikiyatr Ars. 2014 Dec;51(4):376-382
pubmed: 28360657
Exp Neurol. 1997 Oct;147(2):418-27
pubmed: 9344566
Crit Care Clin. 2017 Jul;33(3):461-519
pubmed: 28601132
Exp Mol Med. 2015 Mar 13;47:e149
pubmed: 25766618
Neuroendocrinology. 2006;83(1):12-9
pubmed: 16707911
J Am Geriatr Soc. 2012 Aug;60(8):1471-7
pubmed: 22881707
Arch Gerontol Geriatr. 2006 Sep-Oct;43(2):289-98
pubmed: 16434113
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
Front Cell Neurosci. 2017 Feb 01;11:14
pubmed: 28203146
J Aging Res. 2011;2011:951403
pubmed: 21766035
Int J Geriatr Psychiatry. 2005 Feb;20(2):154-9
pubmed: 15660412
Endocr Rev. 1998 Dec;19(6):717-97
pubmed: 9861545
Front Aging Neurosci. 2017 Nov 03;9:365
pubmed: 29163145
Dev Neurosci. 2017;39(6):443-459
pubmed: 28787734
Acta Psychiatr Scand. 1994 May;89(5):329-34
pubmed: 7915078
BMJ Open. 2013 Jan 07;3(1):
pubmed: 23299110
BMC Med. 2014 Sep 30;12:164
pubmed: 25266390
Pituitary. 2007;10(2):135-9
pubmed: 17410470
Sci Rep. 2016 Feb 05;6:20736
pubmed: 26846868
Front Neurosci. 2016 Feb 23;10:52
pubmed: 26941597
Oncotarget. 2016 May 24;7(21):30049-67
pubmed: 27167199
Endocrinol Metab Clin North Am. 2006 Dec;35(4):793-805, ix-x
pubmed: 17127147